Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied.
Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet.
Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
Category:
Disaster & Management
Latest
Global coronavirus deaths exceed 700,000, one person dies every 15 seconds on average
Even in parts of the world that had appeared to have curbed the spread of the virus, countries have recently seen single-day records in new cases, signaling the battle is far from over. Australia, Japan, Hong Kong, Bolivia, Sudan, Ethiopia, Bulgaria, Belgium, Uzbekistan and Israel all recently had record increases in cases.
Proportion of youth with COVID-19 triples in five months: WHO
An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.
Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.
“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.